Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer
- PMID: 2293558
Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer
Abstract
Twenty-five human bladder tumors were examined for loss of heterozygosity of markers on chromosomes 6p, 9q, 11p, 14q, and 17p. These studies show that all of the markers were reduced to homozygosity in at least some of the tumors. They also confirmed earlier studies by Fearon et al. [Nature (Lond.), 318: 377-380, 1985] that approximately 40% of bladder tumors were reduced to homozygosity for markers on chromosome 11p. However, the greatest frequency of allelic loss was seen for chromosomes 9q (67% of informative cases) and 17p (63% of informative cases) with both chromosomes being lost concordantly in 10 out of 20 informative tumors. Allelic loss of chromosome 9q has not been previously observed with other human cancers; however, deletions of 17p have been reported in breast, lung, and colorectal carcinomas. The data raise the interesting possibility that allelic losses of specific chromosomes might be a feature of cancer in a particular differentiated cell type whereas loss of other chromosomes harboring more generally acting tumor suppressor genes might be a common feature of human cancers.
Similar articles
-
Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.Cancer Res. 1990 Nov 1;50(21):7081-3. Cancer Res. 1990. PMID: 2208176
-
Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.Cancer Res. 1996 Nov 1;56(21):5039-43. Cancer Res. 1996. PMID: 8895761
-
Allelotype of human bladder cancer.Cancer Res. 1994 Jan 15;54(2):531-8. Cancer Res. 1994. PMID: 8275491
-
Detection of genetic aberrations in bladder cancer using in situ hybridization.Ann N Y Acad Sci. 1993 Mar 20;677:199-213. doi: 10.1111/j.1749-6632.1993.tb38778.x. Ann N Y Acad Sci. 1993. PMID: 8098592 Review. No abstract available.
-
Genetic instability in urinary bladder cancer: An evolving hallmark.J Postgrad Med. 2013 Oct-Dec;59(4):284-8. doi: 10.4103/0022-3859.123156. J Postgrad Med. 2013. PMID: 24346386 Review.
Cited by
-
Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction.Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4976-80. doi: 10.1073/pnas.88.11.4976. Proc Natl Acad Sci U S A. 1991. PMID: 2052580 Free PMC article.
-
Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer.Br J Cancer. 2004 Sep 13;91(6):1025-31. doi: 10.1038/sj.bjc.6602073. Br J Cancer. 2004. PMID: 15292937 Free PMC article.
-
P53 accumulation in precursor lesions and early stages of bladder cancer.World J Urol. 1994;12(2):79-83. doi: 10.1007/BF00184241. World J Urol. 1994. PMID: 8087143
-
Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization.Am J Pathol. 1995 Jun;146(6):1341-54. Am J Pathol. 1995. PMID: 7778674 Free PMC article.
-
Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis.PLoS One. 2011;6(9):e24237. doi: 10.1371/journal.pone.0024237. Epub 2011 Sep 1. PLoS One. 2011. PMID: 21909424 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical